EM Vivas · Community-acquired pneumonia
Community-acquired pneumonia — the severity and the empiric antibiotics
A clinical viva on the CURB-65 and the severity-stratified antibiotics.
On this page
Study tools
Target exams
ACEMFRCEMABEM
Prompt
Describe the CURB-65 severity score and how it drives the site of care, and the empiric antibiotic regimen by the severity.
Interpretation
Reveal interpretationShowHide
The CURB-65 score (the five criteria):
- Confusion — the new disorientation.
- Urea raised — above 7 mmol/L.
- Respiratory rate — 30 or above.
- Blood pressure — the systolic below 90 or the diastolic 60 or below.
- 65 — the age 65 or above.
- Each criterion is the one point.
- 0 to 1 — NICE: consider home-based care (low risk, under 3 percent 30-day mortality).
- 2 — consider hospital-based care (intermediate, 3 to 15 percent). Lim's exact score-2 mortality is 3 percent.
- 3 or above — consider intensive-care assessment (high risk, over 15 percent). Not automatic ICU and not an automatic hour-1 antibiotic unless there is shock.[1][3]
Empiric antibiotics (ATS/IDSA 2019; local eTG for the ANZ product):
- Healthy outpatient — amoxicillin 1 g three times daily or doxycycline 100 mg twice daily or a macrolide if pneumococcal macrolide resistance is under 25 percent (not automatically amoxicillin plus a second agent).
- Inpatient non-severe — beta-lactam plus macrolide or a respiratory fluoroquinolone.
- Severe — beta-lactam plus macrolide or beta-lactam plus fluoroquinolone. MRSA/Pseudomonas only with locally validated risk factors. HCAP is abandoned.[2]
Principles: CURB-65 plus judgement; atypical cover in hospitalised CAP; Legionella clues are hyponatraemia, GI and neurological features (not LDH as a rule); cultures must not delay the first dose; duration minimum 5 days plus clinical stability, not a default 14-day Legionella course.[2][1]
References3ShowHide
- [1]Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax, 2003.PMID 12728155
- [2]Metlay JP, Waterer GW, Long AC, et al. Diagnosis and treatment of adults with community-acquired pneumonia. An official clinical practice guideline of the American Thoracic Society and Infectious Diseases Society of America. Am J Respir Crit Care Med, 2019.PMID 31573350
- [3]National Institute for Health and Care Excellence Pneumonia in adults: diagnosis and management (CG191) NICE, 2014.Source